This Solicitation opportunity from Department Of Defense was posted on May 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ACETAZOLAMIDE TABLE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract pertains to the procurement of Acetazolamide Tablets, USP, with each tablet containing 250 mg of the active ingredient. The tablets are supplied in bottles of 100 tablets each, with a total shelf life of 36 months. At the time of receipt by the first government activity, there must be at least 31 months of remaining shelf life. Storage requirements specify maintaining temperatures between 20° to 25°C, with allowable excursions from 15° to 30°C, adhering to USP controlled room temperature standards. The product is for oral administration, prescription only (RX only), and is regulated by the FDA. Packaging and marking must comply with the Defense Logistics Agency (DLA) Medical Marking Standard No. 1, which overrides previous military standards for identification and shipping. Units must be packed in commercial containers designed to protect contents during shipment, with markings ensuring acceptance and safe delivery by carriers. The contract requires delivery within 20 days to a specified location, Fort Carson, with inspection and acceptance occurring at destination. The procurement includes specific technical and quality requirements listed in the DLA Master List, and the contract details vendors authorized to supply the product. The contract is identified under solicitation number SPE2DP-26-T-3390, with a purchase quantity of three bottles.
General Info
Agency
NAICS
Place of Performance
BLDG 7465 BAD TOELZ RD, FORT CARSON, CO, 80913-4093, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ACETAZOLAMIDE TABLETS,USP.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY, ORAL ADMINISTRATION
.
EACH TABLET CONTAINS 250 MILLIGRAMS (MG) OF
ACETAZOLAMIDE, USP AS THE ACTIVE INGREDIENT
.
UNIT OF ISSUE IS A BOTTLE (BT) CONTAINING 100 TABLETS (TT)
.
TOTAL SHELF LIFE IS 36 MONTHS.
SPE2DP-26-T-3390
SECTION B
.
THERE SHALL BE A MINIMUM OF 31 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 20° TO 25°C (68° TO 77°F) EXCURSIONS PERMITTED
BETWEEN 15 AND 30°C (59 TO 86°F)
[SEE USP CONTROLLED ROOM TEMPERATURE]
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
6/22/2016
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
1 BT = 100 TT RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135-0567-01 AVKARE LLC 4QGW8 P/N NDC42291-0090-01 TARO PHARMACEUTICALS U.S.A., INC. 3HFB6 P/N NDC51672-4023-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0034-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016240834 0001 BT 3.000
NSN/MATERIAL:6505006640857
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-664-0857 Quantity: 3 BT Purchase Request: 7016240834QTY: 3 Delivery: 20 days ADO
